Please login to the form below

Not currently logged in
Email:
Password:

rilpivirine

This page shows the latest rilpivirine news and features for those working in and with pharma, biotech and healthcare.

ViiV chalks up another win for two-drug HIV regimen

ViiV chalks up another win for two-drug HIV regimen

After switching to the injectable regimen of integrase inhibitor cabotegravir and Johnson &Johnson’s non-nucleoside RTI rilpivirine, the patients showed similar efficacy after 48 weeks’treatment, with ViiV’s combination ... Meanwhile, in May it

Latest news

More from news
Approximately 3 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics